Massey awarded American Cancer Society Institutional Research Grant for 40th year
For 40 years, the American Cancer Society (ACS) has continuously awarded VCU Massey Cancer Center $270,000 Institutional Research Grants (IRGs). The ACS-IRGs are awarded as block grants to prestigious institutions to provide funding for young investigators with an interest in cancer research.
New drug combination in preclinical studies effectively treats brain and breast cancer, Ebola, influenza and many other viruses and superbug bacteria
Scientists at Virginia Commonwealth University Massey Cancer Center have developed a drug combination that kills brain and breast cancer stem cells in preclinical studies. The breakthrough drug combination also prevents viruses, including Ebola, from replicating and makes “superbug” bacteria vulnerable to common antibiotics.
New target identified for potential brain cancer therapies
Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center and the VCU Institute for Molecular Medicine (VIMM) have identified a new protein-protein interaction that could serve as a target for future therapies for the most common form of brain cancer, glioblastoma multiforme (GBM).
Her laugh is the best sound in the world
Mackenzie was just 20 months old when the team at VCU Massey Cancer Center removed a peach-sized tumor from her brain. This Christmas, she’s celebrating her 10th birthday.
Massey researchers and physicians receive VCU Faculty Excellence Awards
VCU Massey Cancer Center physicians and researchers were recently honored at the VCU School of Medicine’s 16th Annual Faculty Excellence Awards. Established in 1999, these awards formally recognize exceptional faculty for their leadership, mentorship and professional excellence.